GDM Survey
Why are we doing this study?
Gestational Diabetes Mellitus (GDM) is a type of diabetes that affects some people during pregnancy and is sometimes referred to as ‘pregnancy induced diabetes’. The body’s need for insulin (a hormone that helps sugar get into the cells) increases during pregnancy, and GDM can occur when the body cannot make enough insulin. Having GDM during pregnancy can increase the risk of other pregnancy complications, such as having a larger sized baby, pre-eclampsia (a condition that causes high blood pressure) and having a Caesarean section birth. Current data on the best timing for induction of labour for patients with GDM is inconclusive. International guidelines differ in timing of induction of labour, varying from 37-weeks to 39-weeks of pregnancy. A randomized control trial would allow us to assess the outcomes associated with the induction of labour at 38-weeks’ gestation compared to current expectant management.
To help inform and develop the design of a future clinical trial, our research team would like to gain insight from patients and health care providers to assess their opinions in participating or supporting a clinical trial to evaluate induction of labour at 38-weeks’ gestation compared to current expectant management in those pregnancies with GDM.
Who can participate?
We are inviting patients and health care providers to complete a 5-minute survey to obtain their perspectives on participating in a clinical trial.
Patients are eligible to complete this survey if they:
- are at least 16 years old, AND
- are currently pregnant, AND
- have been diagnosed with diabetes in their current pregnancy, AND
- able to comprehend and communicate in English or French
Health care providers are eligible to complete this survey if:
- they are currently providing care to the pregnant population, AND
- their professional status allows them to counsel pregnant people on pregnancy, including delivery recommendations, AND
- able to comprehend and communicate in English
How can you participate?
Questions:
If you have any questions about this study, please contact the research team.
By phone at 613-737-8899 ext. 73840 or email at omniresearch@toh.ca.
Note: Email is considered a non-secure form of communication as it may be accessed by unauthorized third parties.
